FOXO4-DRI is a peptide antagonist designed to block the interaction of forkhead box O 4 (FOXO4) and p53.
FOXO4-DRI peptide is a synthetic, cell-permeable peptide derived from the forkhead box O4 (FOXO4) transcription factor, designed to disrupt the interaction between FOXO4 and p53 proteins. As a research tool, it has gained significant attention within cellular senescence studies, aging research, and the broader field of signal transduction. By mimicking a specific domain of the endogenous FOXO4 protein, FOXO4-DRI enables precise modulation of protein-protein interactions that are pivotal in cellular fate decisions. Its unique mechanism of action and selectivity make it a valuable reagent for dissecting pathways related to senescence and apoptosis in various biological models.
Senescence research: FOXO4-DRI is widely utilized in studies investigating the molecular mechanisms underlying cellular senescence. By selectively interfering with the endogenous FOXO4-p53 binding, the peptide enables researchers to induce targeted disruption of senescence-associated signaling pathways. This facilitates the exploration of how FOXO4 contributes to the maintenance of the senescent phenotype, allowing for deeper insights into the regulation of cell cycle arrest, chromatin remodeling, and the senescence-associated secretory phenotype (SASP) in both primary and immortalized cell lines.
Signal transduction analysis: In the context of signal transduction research, FOXO4-DRI serves as a precise modulator for delineating the downstream effects of FOXO transcription factors. Its ability to selectively inhibit FOXO4-mediated interactions provides a means to study the cross-talk between stress response pathways and apoptotic regulators. This is particularly valuable for mapping the intricate networks that govern cell survival, DNA damage responses, and oxidative stress adaptation, thereby supporting the identification of novel regulatory nodes within these critical biological processes.
Aging and longevity models: The peptide is frequently employed in experimental models of aging to interrogate the role of FOXO4-p53 interactions in tissue homeostasis and organismal lifespan. By enabling the selective elimination of senescent cells, FOXO4-DRI facilitates studies aimed at understanding how the accumulation or removal of such cells impacts aging phenotypes and tissue regeneration. This application supports research efforts to unravel the complex interplay between cellular senescence, tissue function, and age-associated decline in various mammalian systems.
Apoptosis pathway investigation: FOXO4-DRI is also instrumental in dissecting the molecular determinants of programmed cell death. Through its targeted disruption of FOXO4-p53 complexes, the peptide allows researchers to investigate the balance between cell survival and apoptosis in response to genotoxic or oxidative stress. Such studies are critical for elucidating the checkpoints that determine cellular fate, offering insights into the mechanisms by which cells evade apoptosis and the potential reversibility of senescence.
Peptide-based tool development: Beyond its direct use in biological assays, FOXO4-DRI serves as a model for the rational design of peptide-based inhibitors targeting protein-protein interactions. Its structure-function characteristics provide a foundation for the development of next-generation research reagents aimed at modulating transcription factor networks. Researchers leverage FOXO4-DRI as a benchmark in the optimization of cell-penetrating peptides, sequence-specific inhibitors, and targeted modulators for use in advanced biochemical and cellular applications.
1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More